Endoplasmic Reticulum Stress and Insulin Biosynthesis: A Review by Mi-Kyung Kim et al.
Hindawi Publishing Corporation
Experimental Diabetes Research
Volume 2012, Article ID 509437, 7 pages
doi:10.1155/2012/509437
Review Article
EndoplasmicReticulumStressandInsulinBiosynthesis:AReview
Mi-Kyung Kim,1 Hye-Soon Kim,1 In-KyuLee,2 andKeun-GyuPark2
1Department of Internal Medicine, Keimyung University School of Medicine, Daegu 700-712, Republic of Korea
2World Class University Program, Department of Internal Medicine, Kyungpook National University School of Medicine,
Daegu 700-721, Republic of Korea
Correspondence should be addressed to Keun-Gyu Park, kpark@knu.ac.kr
Received 14 April 2011; Accepted 6 December 2011
Academic Editor: Muthuswamy Balasubramanyam
Copyright © 2012 Mi-Kyung Kim et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Insulin resistance and pancreatic beta cell dysfunction are major contributors to the pathogenesis of diabetes. Various conditions
play a role in the pathogenesis of pancreatic beta cell dysfunction and are correlated with endoplasmic reticulum (ER) stress.
Pancreatic beta cells are susceptible to ER stress. Many studies have shown that increased ER stress induces pancreatic beta cell
dysfunction and diabetes mellitus using genetic models of ER stress and by various stimuli. There are many reports indicating
that ER stress plays an important role in the impairment of insulin biosynthesis, suggesting that reduction of ER stress could be
a therapeutic target for diabetes. In this paper, we reviewed the relationship between ER stress and diabetes and how ER stress
controls insulin biosynthesis.
1.Introduction
1.1. Diabetes and ER Stress. The endoplasmic reticulum
(ER), a membrane compartment located near the nucleus,
is the organelle where polypeptides, which will become
secretory proteins or membrane proteins, are synthesized
from mRNA and become mature proteins after undergoing
folding, assembly, glycosylation, disulﬁde bonding, and
posttranslationalmodiﬁcations[1].TheERiswelldeveloped
inendocrinecellssuchaspancreaticbetacellsinwhichsecre-
tory proteins are synthesized. Proper functioning of the ER is
essential to cell survival. ER stress is deﬁned as an imbalance
between client protein load and folding capacity and can
be caused by multiple mechanisms including increases in
improperly folded proteins, impairment of protein transport
from the ER to the Golgi, inhibition of protein glycosylation,
reduced disulﬁde bond formation, and calcium depletion
of the ER lumen. When ER stress occurs, cellular defense
mechanisms related to the ER stress response are activated.
The ER stress response is comprised of (1) activation of
the protein-kinase-RNA-(PKR-) like ER kinase (PERK) and
reduction of protein translation by phosphorylation of the
eukaryotic translation initiation factor 2 alpha (eIF2α); (2)
activationoftheinositol-requiring1(IRE1)/X-box-binding-
protein- 1 (XBP-1) protein and the activating transcription
factor 6 (ATF6) through the increased expression of ER
chaperones and subsequent increase in ER folding capacity;
(3) ER stress-associated protein degradation, which degrades
unfolded or improperly folded proteins; (4) apoptosis by the
activation of CCAAT/enhancer-binding homologous protein
(CHOP) [2–4].
Type 2 diabetes is characterized by insulin resistance
and pancreatic beta cell dysfunction. Pancreatic beta cells
compensate for insulin resistance by hypersecretion of
insulin; however, at some point, pancreatic beta cells fail
to secrete suﬃcient insulin, resulting in diabetes [5]. The
pancreatic beta cells are susceptible to ER stress not only
because of physiological variations in glucose levels that
potently stimulate insulin translation but also because of
other conditions that can cause ER stress such as metabolic
dysregulation associated with obesity, including excess nutri-
ents [6–10] and inﬂammatory cytokines [11–13]. Obesity
canalsocontributetoinsulinresistanceviaERstress[14,15].
In addition, many studies have shown that increased ER
stress induces pancreatic beta cell dysfunction and diabetes
mellitus using genetic models of ER stress [16–24].
1.2.GlucotoxicityorLipotoxicity. Fortype2diabeticpatients,
a common clinical course is to respond to therapy initially by
normalizing their fasting glucose levels, but then to undergo2 Experimental Diabetes Research
gradual deterioration in glycemic control, despite optimal
medical management using a variety of drugs [25]. Although
optimal management of type 2 diabetes regulates fasting
glucose levels, most patients continue to have abnormally
elevated postprandial glucose levels, which results in glu-
cotoxicity [26]. Glucotoxicity is deﬁned as nonphysiological
and potentially irreversible pancreatic beta cell damage
caused by chronic exposure to supraphysiological glucose
concentrations [26]. Supraphysiological glucose concentra-
tions also have adverse eﬀects on cellular structure and
function in tissues throughout the body. Chronic exposure
to high glucose concentrations in HIT-T15 cells over 50
weeks caused a decrease in insulin gene transcription factors
such as pancreatic-duodenal-homeobox-factor-1 (PDX-1)
and MafA, insulin promoter activity, insulin mRNA, insulin
content, and insulin secretion [27–31]. Glucotoxicity implies
damage and irreversibility and should be diﬀerentiated
from desensitization and exhaustion, which are reversible
phenomena [32].
Obesityisamajorpredisposingfactorfortype2diabetes.
The increase in free fatty acids (FFAs) due to obesity causes
insulin resistance and, as a consequence, pancreatic beta cells
secrete more insulin to compensate for insulin resistance and
maintain normoglycemia. However, failure to compensate
for insulin resistance by the pancreatic beta cells results in
beta cell dysfunction and diabetes [5]. This phenomenon,
which is a lipid-induced pancreatic beta cell dysfunction, is
lipotoxicity. Chronic exposure to FFAs results in decreased
insulin gene expression and proinsulin processing [33]
and increased pancreatic beta cell death [34]. Recently,
the concept of “glucolipotoxicity” has been introduced
because lipotoxicity is dependent on elevated glucose levels
and elevated glucose and FFAs have a synergistic eﬀect
on impairing pancreatic beta cell function [35]. Recently,
increasing evidence has implicated ER stress in glucotoxicity
and glucolipotoxicity in pancreatic beta cells [6, 9, 10].
1.3. Insulin Biosynthesis. Pancreatic-beta-cell-speciﬁc ex-
pression of the insulin gene requires both ubiquitous and
cell-speciﬁc activators, which have target sequences within
the enhancer located between −340 and −90 nucleotides
relative to the transcription start site [36, 37]. Transcription
of the insulin gene is regulated primarily by transcription
factors such as PDX-1, BETA/NeuroD, and RIPE3b1/MafA.
Under physiological conditions, MafA and PDX-1 bind to
the C elements and the A boxes, respectively. Glucotox-
icity greatly diminishes protein levels of PDX-1 through
a posttranscriptional mechanism, and of MafA through a
posttranslational mechanism. These abnormalities lead to
decreases in insulin mRNA, insulin content, and glucose-
induced insulin secretion [28, 30].
The ER plays an important role in the biosynthesis of
insulin since the early steps of insulin biosynthesis occur
in the ER [38]. The insulin gene encodes the preproinsulin
polypeptide. Insulin is the posttranslational product of
preproinsulin and is a globular protein containing two
chains, A (21 residues) and B (30 residues). As preproinsulin
is synthesized in the cytoplasm with a signal peptide, it
is cotranslationally translocated into the lumen of the ER
through the interaction between the signal peptide and the
signal recognition particle on the ER membrane. The signal
peptide of preproinsulin is cleaved in the ER and proinsulin
is produced. In the lumen of the ER, proinsulin undergoes
protein folding whereby three disulﬁde bonds are formed,
which are essential for stability and bioactivity. Properly
folded proinsulin is then delivered to the Golgi apparatus
and packaged into secretory granules [39]. The conversion
of proinsulin to insulin takes place in the secretory granules.
Mature insulin is then released by exocytosis [40]. Therefore,
ER stress due to increased misfolded proinsulin may induce
beta cell dysfunction and diabetes.
Various conditions that are associated with diabetes
mellitus, such as glucotoxicity and lipotoxicity, have been
implicated in ER stress in pancreatic beta cells [41–43]. This
paper focuses on the relationship between ER stress and
insulin gene biosynthesis.
2. PERK/ATF4
When unfolded proteins accumulate in the ER lumen, the
ﬁrst response is to attenuate further translation of mRNAs,
which reduces the ER load of new protein, preventing
further accumulation of unfolded protein. This translational
attenuation is mediated by PERK/eIF2α [19, 44]. In response
to ER stress, eIF2α is phosphorylated by PERK. EIF2α is a
heterotrimeric protein that is required to bring the initiator
methionyl-transferRNA(Met-tRNA)totheribosome.PERK
is a type I transmembrane serine/threonine kinase localized
in the ER membrane. Under unstressed conditions, the ER
chaperone Bip binds to the ER luminal domain of PERK and
maintains this protein in an inactive form. Upon induction
of ER stress, Bip binds to unfolded proteins and is thus com-
petitively dissociated from PERK, leading to the activation
of PERK by oligomerization and trans-autophosphorylation.
Consequently, activated PERK phosphorylates eIF2α and
inhibits translation [3, 44]. Phosphorylated eIF2α promotes
expression of stress-induced genes, such as the transcription
factors ATF4 and CHOP [22]. Moreover, in response to
long-term adaptation to stress conditions, phosphorylation
of eIF2α induces the expression of the growth arrest and
DNA damage gene, GADD34. GADD34 is a stress-inducible
regulatory subunit of a holophosphatase complex that
dephosphorylates eIF2α together with protein phosphatase
1c (PP1c), and is an important component of translational
recovery during the ER stress response [45, 46].
Many studies have reported the relationship between
PERK and diabetes [18–20, 47–49]. Wolcott-Rallison syn-
drome indicates that the PERK gene is correlated with dia-
betes. Wolcott-Rallison syndrome is a rare human autosomal
recessive genetic disorder characterized by early infancy type
1 diabetes resulting from mutations in the PERK gene [18,
47]. A similar phenotype has been described in PERK-/-
mice [19]. The exocrine and endocrine pancreases develop
normally in Perk-/- mice, but there is a progressive loss
of insulin-producing pancreatic beta cells in the islets of
Langerhans of Perk-/- mice postnatally, resulting in hyper-
glycemia and reduced serum insulin levels. Moreover, ER
distention and activation of the ER stress transducer IRE1α,Experimental Diabetes Research 3
accompanied by increased cell death, leads to progressive
diabetes mellitus and exocrine pancreatic insuﬃciency [19].
Zhangetal.reportedthatPERK-deﬁcientmiceexhibitsevere
defectsinfetal/neonatalpancreaticbetacellproliferationand
diﬀerentiation, resulting in low pancreatic beta cell mass,
defects in proinsulin traﬃcking, and abrogation of insulin
secretion, which together culminate in permanent neonatal
diabetes [20]. Yusta B et al. reported that exendin-4, a GLP-
1 receptor agonist, reduced the downregulation of insulin
translation and improved cell survival under ER stress
conditions.Exendin-4increasedATF4andCHOPexpression
and also potentiated the induction of GADD34 and PP1c
activity, resulting in decreased phosphorylation of eIF2α
and a faster recovery from translational repression. These
ﬁndings show that GLP-1 receptor signaling modulates the
ER stress response, leading to enhanced pancreatic beta cell
survival [48].
3.IRE/XBP
The second response to ER stress is an increase in pro-
teinfolding activity via the induction of ER chaperones
such as Bip. This response is mediated by IRE1 and ATF6.
IRE1 is a type I transmembrane endonuclease localized in
the ER membrane. Similar to PERK, activation of IRE1
is triggered by dissociation of Bip from the IRE1 ER
luminal domain, which leads to oligomerization and trans-
autophosphorylation.Subsequently,IRE1inducessplicingof
XBP-1, which upregulates unfolded protein response (UPR)
target genes [2–4, 50]. IRE-XBP-1 signaling is important
in secretory cells, such as exocrine pancreatic cells [51].
Lipson et al. reported that chronic hyperglycemiainduces ER
stress and activates IRE1, resulting in suppression of insulin
expression at the transcriptional level [7]. Transient high
glucose conditions induced the activation of IRE1α in pan-
creatic islet cells. Inactivation of IRE1α signaling by siRNA
or inhibition of IRE1α phosphorylation decreases insulin
biosynthesis under the transient high glucose conditions.
However,IRE1activationbyhighglucoseconcentrationswas
not accompanied by Bip dissociation and XBP-1 splicing,
but IRE1 target genes were upregulated. These ﬁndings
suggest that under transient high glucose conditions like
postprandialhyperglycemia,IRE1αisactivatedandenhances
proinsulin biosynthesis. By contrast, sustained activation
of IRE1 signaling by chronic high glucose exposure causes
ER stress, leading to the suppression of insulin mRNA
expression. These ﬁndings suggested that sustained acti-
vation of IRE1α may decrease insulin biosynthesis at the
transcriptional level. Overall, physiological IRE1α activation
by transient high glucose conditions has a beneﬁcial eﬀect,
but pathological IRE1α activation by chronic high glucose
exposure is harmful to cells. In addition, under transient
hyperglycemic conditions, activation of IRE1α was not
accompanied by XBP-1 splicing, but long-term exposure to
high glucose induced IRE1α activation and XBP-1 splic-
ing, suggesting that XBP-1 splicing could be a marker of
chronic hyperglycemic conditions [7] .P i r o te ta l .r e p o r t e d
that IRE/XBP-1 increases degradation of insulin mRNA.
Cyclopiazonic acid (CPA) is a sarcoendoplasmic reticulum
Ca2+-ATPase (SERCA) blocker, which depletes ER calcium
stores and induces ER stress. When INS-1 cells were treated
with CPA, insulin mRNA levels decreased. Treatment with
CPA did not aﬀect insulin promoter activity, indicating
that the decrease in insulin mRNA was not caused by a
decreaseininsulintranscription.Bycontrast,whencellswere
pretreated with actinomycin D, which arrests transcription,
treatment with CPA induced a decrease in insulin expression
that was due to mRNA degradation. Moreover, this study
showed that insulin mRNA degradation in response to
CPA was paralleled by an increase in IRE1 activation [52].
Another study has suggested that sustained production of
spliced XBP-1 (XBP-1s) induces beta cell dysfunction by
decreasinginsulingeneexpression,leadingtoapoptosis [53].
Adenoviral-mediated overproduction of XBP-1s resulted in
increased XBP-1 activity and increased expression of XBP-
1 target genes. XBP-1s overexpression impaired glucose-
stimulated insulin secretion, increased beta cell apoptosis,
and decreased levels of insulin, Pdx1, and Mafa mRNA.
XBP-1s knockdown partially restored cytokine/ER-stress-
driven insulin and Pdx1 inhibition. These data suggest that
prolonged XBP-1s production induces beta cell dysfunction
through inhibition of Pdx1, MafA, and insulin expression
leading to beta cell apoptosis [53].
4. ATF6
ATF 6 is another mediator of ER- stress-induced transcrip-
tion. ATF6 is a member of the ATF, cAMP response element-
binding protein, basic-leucine zipper (bZIP) DNA-binding
protein family of transcriptional activators [54]. ATF6 is a 90
kDaprotein(p90ATF6)of670aminoacids[55]andcontains
a transmembrane domain (amino acids 378–398) with the N
terminus facing the cytoplasm [56]. In the unstressed state,
p90ATF6 is localized to the ER [56]. In response to ER stress,
ATF6 translocates from the ER to the Golgi [56, 57], where
it is cleaved by site 1 and site 2 proteases [58]. Proteolytic
cleavage of ATF6 removes the N-terminal cytosolic domain,
which is transported into the nucleus and directly induces
transcriptional activation of chaperone molecules such as
BIP/GRP78 and other enzymes that are essential for protein
folding [56, 58–60]. Moreover, activated ATF6 directly binds
to the ER stress response element (ERSE) and induces XBP-1
expression.
The spliced form of XBP-1 is produced from the upregu-
latedXBP-1mRNAbyactivationofIRE1αandbindstoERSE
sequencesdirectly.WhenERstressoccurs,activationofATF6
is rapid because it is produced from a preexisting precursor
protein, whereas activation of XBP-1 is slow because XBP-1
mRNA must be induced, spliced, and translated to produce
an active form of XBP-1. This observation suggests that
ATF6 is activated early in response to ER stress and XBP-1
functions in more sustained ER stress [61, 62]. A prolonged
increase in the demand for insulin often leads to defects in
insulin secretion, resulting in sustained hyperglycemia [63].
Chronic hyperglycemia has deleterious eﬀects on beta cell
function, as shown in primary cultured rat and human islet
cells and in beta cell lines [64].4 Experimental Diabetes Research
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Figure 1: Possible mechanisms of insulin biosynthesis by endoplasmic reticulum (ER) stress. Insulin biosynthesis is aﬀected by ER stress
through diﬀerent mechanisms, such as activation of the following pathways: transcription factor 6 (ATF6), inositol-requiring 1 (IRE1)/X-
box-binding-protein-1 (XBP-1), and protein-kinase-RNA (PKR-) like ER kinase (PERK). The exposure of beta cells to high glucose
chronically induces ER stress, resulting in the activation of ATF6. Activation of ATF6 impairs insulin gene expression. Long-term exposure
to high glucose induces IRE1α activation and XBP-1 splicing, leading to the suppression of insulin mRNA expression and to increases in the
degradationofinsulinmRNA.Inaddition,downstreamofPERK,ATF4,andCHOPinhibitproinsulinsynthesisviatranslationalattenuation
mediated by PP1c and GADD34. Numbers in parentheses are the references cited in this paper.
Previously, our studies conﬁrmed that chronic high
glucose induces beta cell dysfunction. Under basal glu-
cose concentrations (5mmol/l glucose), insulin mRNA is
expressed abundantly in INS-1 cells, but, in the presence of
30mmol/l glucose, insulin mRNA expression was decreased
in a time-dependent manner until only minimal levels were
detected by 96h. The expression of PDX-1 and MafA,
which are the main transcription factors associated with
insulin gene expression, also decreased over time in the
30mmol/l glucose [65]. In addition, chronic hyperglycemia
induced ER- stress in cultured INS-1 cells and ER stress-
induced activation of ATF6 impaired insulin gene expression
via upregulation of the orphan nuclear receptor small
heterodimer partner (SHP). Prolonged exposure of INS-
1 cells to a high concentration of glucose increased ER
stress in the cells, and ER stress induced by the chemical
ER stressors tunicamycin, thapsigargin, and DTT impaired
insulin gene expression. Among the three diﬀerent signaling
pathways of the ER stress response (ATF6, IRE1, and
PERK), ATF6 inhibited insulin promoter activity, but IRE1-
XBP1 and PERK-eIF2α-ATF4 did not. Adenovirus-mediated
overexpressionoftheactiveformofATF6(Ad-ATF6)inINS-
1 cells down-regulated PDX-1 and MafA gene expression
and repressed the cooperative action of PDX-1, BETA2, and
MafA in stimulating insulin transcription [66].
Several in vitro studies have shown that SHP negatively
regulates insulin biosynthesis and secretion in pancreatic
beta cells [67]. SHP also directly represses the transcriptional
activity of the basic helix-loop-helix transcription factor
BETA2, a positive regulator of insulin gene expression [68],
and indirectly represses p300-enhanced BETA2/NeuroD
transcriptional activity through inhibition of the BETA2-
p300 interaction [69]. Previously, we reported that gluco-
toxicity in INS-1 cells is mediated by SHP. Culture of INS-
1 cells and rat pancreatic islets in the continuous pres-
ence of high glucose concentrations increased SHP mRNAExperimental Diabetes Research 5
expression, followedby a decreasein insulin gene expression.
Furthermore, adenovirus-mediated overexpression of SHP
in INS-1 cells impaired glucose-stimulated insulin secretion
as well as insulin gene expression [65]. Interestingly, Ad-
ATF6 increased SHP gene expression, and downregulation
of endogenous SHP expression by siRNA-SHP blocked
ATF6-induced suppression of insulin gene expression. These
data suggest that ER-stress-induced beta cell dysfunction is
mediated, at least in part, by ATF6-induced transcriptional
activation of SHP. Collectively, chronic high glucose expo-
sure induced ER stress, and ER stress-induced activation of
ATF6 resulted in beta cell dysfunction mediated, in part, by
the upregulation of SHP expression [66].
5. Conclusions
ManystudieshavereportedthatERstressplaysanimportant
role in the pathogenesis of diabetes and that the UPR
has an important role in regulating pancreatic beta cell
functions. These studies have suggested that resolving ER
stress could be a therapeutic target for diabetes. Moreover, it
hasbeensuggestedfromexperimentalevidencethatERstress
mediates glucolipotoxicity-induced suppression of insulin
biosynthesis (Figure 1). In addition to impaired insulin
biosynthesis, understanding impaired insulin secretion and
beta cell failure, including apoptosis in glucolipotoxicity-
induced ER stress conditions, could have important implica-
tions for the development of therapeutic strategies for type
2 diabetes mellitus. However, we do not know completely
how ER stress aﬀects the pathogenesis of human diabetes.
To clarify the role of ER stress in insulin biosynthesis,
investigations to determine whether ER stress is implicated
in the development of human diabetes and the interaction
of the three arms of ER stress are needed. Besides, it will
be important for future studies to address the relationship
between the ER stress response gene and human disease by
performing a genetic study.
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